Phase: IIa

A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Knee Osteoarthritis Associated with Bone Marrow Lesions.

Sponsor:
Axsome Therapeutics
CRO:
N/A
Study ID:
AXS02-K301 COAST-1
Phase:
IIa

A Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Multiple Center, Multiple-Dose Study to Assess the Efficacy and Safety of ZYN002 Administered as a Transdermal Gel to Patients with Knee Pain due to Osteoarthritis.

Sponsor:
Zynerba Pharmaceuticals
CRO:
Novotech
Study ID:
ZYN2-CL-005
Phase:
IIa

A Phase IIa, Randomized, Double-blinded, Placebo-controlled, Dose-finding Study for Single-Dose Administration of TLC599 in Patients with Osteoarthritis (OA) of Knee.

Sponsor:
Taiwan Liposome Company
CRO:
Novotech
Study ID:
TLC559A2003
Phase:
IIa